Ignite Creation Date:
2024-05-06 @ 1:26 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04028245
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2019-07-18
Brief Title:
A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
Sponsor:
Columbia University
Organization:
Columbia University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-18
First Submit QC Date:
July 18 2019
Study First Post Date:
2019-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-05
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL